<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_dUkkKbv">Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality</title>
				<funder ref="#_txCPGkg">
					<orgName type="full">NHMRC Centre for Research Excellence in Suicide Prevention</orgName>
				</funder>
				<funder>
					<orgName type="full">National Health and Medical Research Council</orgName>
					<orgName type="abbreviated">NHMRC</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000925</idno>
				</funder>
				<funder ref="#_3H2scPd">
					<orgName type="full">NHMRC</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>BSc(Hons) BA</roleName><forename type="first">Jennifer</forename><surname>Nicholas</surname></persName>
							<email>j.nicholas@blackdog.org.au</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Black Dog Institute , University of New South Wales , Sydney , Australia</note>
								<orgName type="department">Black Dog Institute</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> School of Psychiatry , Faculty of Medicine , University of New South Wales , Sydney , Australia</note>
								<orgName type="department" key="dep1">School of Psychiatry</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>BSc(Hons) BA</roleName><forename type="first">Mark</forename><forename type="middle">Erik</forename><surname>Larsen</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Black Dog Institute , University of New South Wales , Sydney , Australia</note>
								<orgName type="department">Black Dog Institute</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Judith</forename><surname>Proudfoot</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Black Dog Institute , University of New South Wales , Sydney , Australia</note>
								<orgName type="department">Black Dog Institute</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Helen</forename><surname>Christensen</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Black Dog Institute , University of New South Wales , Sydney , Australia</note>
								<orgName type="department">Black Dog Institute</orgName>
								<orgName type="institution">University of New South Wales</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Black Dog Institute University of New South Wales Hospital Road , Prince of Wales Hospital Randwick Sydney , 2031 Australia</note>
								<orgName type="institution">Black Dog Institute University of New South Wales</orgName>
								<address>
									<addrLine>Hospital Road Prince of Wales Hospital Randwick</addrLine>
									<postCode>2031</postCode>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_JezzyjX">Mobile Apps for Bipolar Disorder: A Systematic Review of Features and Content Quality</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">9E170B4A814578E279A95F74A0041475</idno>
					<idno type="DOI">10.2196/jmir.4581</idno>
					<idno type="PMID">26283290</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:57+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_3FxRKHH">mobile applications</term>
					<term xml:id="_yVrHgD6">bipolar disorder</term>
					<term xml:id="_BNSm2MB">review</term>
					<term xml:id="_7cxmpKA">telemedicine</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_MWeAxZ4"><p xml:id="_s9Rn3Fm"><s xml:id="_DMyZu2P">Background: With continued increases in smartphone ownership, researchers and clinicians are investigating the use of this technology to enhance the management of chronic illnesses such as bipolar disorder (BD).</s><s xml:id="_8HjVZW7">Smartphones can be used to deliver interventions and psychoeducation, supplement treatment, and enhance therapeutic reach in BD, as apps are cost-effective, accessible, anonymous, and convenient.</s><s xml:id="_Sa5kqhs">While the evidence-based development of BD apps is in its infancy, there has been an explosion of publicly available apps.</s><s xml:id="_JfPzJTj">However, the opportunity for mHealth to assist in the self-management of BD is only feasible if apps are of appropriate quality.</s></p><p xml:id="_xQy5zDc"><s xml:id="_2umpTtH">Objective: Our aim was to identify the types of apps currently available for BD in the Google Play and iOS stores and to assess their features and the quality of their content.</s></p><p xml:id="_PNE7Njy"><s xml:id="_spMGat4">Methods: A systematic review framework was applied to the search, screening, and assessment of apps.</s><s xml:id="_taMfz6M">We searched the Australian Google Play and iOS stores for English-language apps developed for people with BD.</s><s xml:id="_7aJDrET">The comprehensiveness and quality of information was assessed against core psychoeducation principles and current BD treatment guidelines.</s><s xml:id="_S6TpHNW">Management tools were evaluated with reference to the best-practice resources for the specific area.</s><s xml:id="_uRDJZC6">General app features, and privacy and security were also assessed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QB74bFB">Results:</head><p xml:id="_sNAU6jC"><s xml:id="_K22yXEz">Of the 571 apps identified, 82 were included in the review.</s><s xml:id="_U4H68Bh">Of these, 32 apps provided information and the remaining 50 were management tools including screening and assessment (n=10), symptom monitoring (n=35), community support (n=4), and treatment (n=1).</s><s xml:id="_RXYbtVF">Not even a quarter of apps (18/82, 22%) addressed privacy and security by providing a privacy policy.</s><s xml:id="_Xw3WGyN">Overall, apps providing information covered a third (4/11, 36%) of the core psychoeducation principles and even fewer (2/13, 15%) best-practice guidelines.</s><s xml:id="_KQa3xkG">Only a third (10/32, 31%) cited their information source.</s><s xml:id="_8BKqKpf">Neither comprehensiveness of psychoeducation information (r=-.11,</s><s xml:id="_xDY9bHp">P=.80) nor adherence to best-practice guidelines (r=-.02,</s><s xml:id="_FQV2GQB">P=.96) were significantly correlated with average user ratings.</s><s xml:id="_F339Nr5">Symptom monitoring apps generally failed to monitor critical information such as medication (20/35, 57%) and sleep (18/35, 51%), and the majority of self-assessment apps did not use validated screening measures (6/10, 60%).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8Fxst9D">Conclusions:</head><p xml:id="_dcNa3FQ"><s xml:id="_sFWfNdV">In general, the content of currently available apps for BD is not in line with practice guidelines or established self-management principles.</s><s xml:id="_wMshavR">Apps also fail to provide important information to help users assess their quality, with most lacking source citation and a privacy policy.</s><s xml:id="_pVmMk8a">Therefore, both consumers and clinicians should exercise caution with app selection.</s><s xml:id="_unS9Fre">While mHealth offers great opportunities for the development of quality evidence-based mobile interventions, new frameworks for mobile mental health research are needed to ensure the timely availability of evidence-based apps to the public.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SGbBYX8">Introduction</head><p xml:id="_Qq4BDGu"><s xml:id="_p4vkKrb">Symptom monitoring is a fundamental component of the self-management of bipolar disorder (BD) that benefits from being performed in real-time and under natural conditions <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_gdX2uQP">With mobile phone penetration reaching 97% worldwide, and smartphones accounting for the majority of phone sales in 2014 <ref type="bibr" target="#b1">[2]</ref>, researchers and clinicians are investigating the use of smartphone technology to enhance the management of chronic illnesses such as BD.</s><s xml:id="_3uf4f7s">As smartphones are personal devices that are carried on the user, mobile apps are a perfect platform for self-management.</s><s xml:id="_22GS9FN">Smartphones can also be used to deliver interventions and psychoeducation, supplement treatment, and enhance therapeutic reach in BD, as apps are cost-effective, accessible, anonymous, and convenient.</s></p><p xml:id="_NHPGv9g"><s xml:id="_febqP6v">A study by Proudfoot et al <ref type="bibr" target="#b2">[3]</ref> found that consumers hold positive attitudes towards evidence-based mental health apps, with 76% of survey responders indicating that they would be interested in using their smartphones for monitoring and self-management of mental health.</s><s xml:id="_AAG8nW9">This acceptability has also been shown in mobile programs for BD, with personal digital assistant <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref> and short message service based interventions <ref type="bibr" target="#b0">[1]</ref> proving effective and acceptable to consumers.</s><s xml:id="_nVGMeCw">Similar programs are now being developed for smartphones.</s><s xml:id="_9n3TKXP">For instance, Wenze et al <ref type="bibr" target="#b5">[6]</ref> are developing an expanded smartphone version of their successful PDA-based "Increasing Adherence in Bipolar Disorder" intervention, which will incorporate psychoeducation and Cognitive Behavioral Therapy (CBT) sessions using smartphones alongside in-person treatment to address medication adherence.</s><s xml:id="_zUKWAmz">A smartphone app based on Interpersonal and Social Rhythms Therapy (IPSRT) augmented with objective data from phone sensors is also in production.</s><s xml:id="_H8qvJvX">This app, called "MoodRhythm", aims to stabilize daily routines and rhythms to prevent episode-onset <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_mWSX92H">Also investigating the potential use of objective data alongside self-report, the monitoring, treatment, and prediction of bipolar disorder episodes (MONARCA) study app attempts to validate objective indicators of affect change by investigating correlations with user-inputted and clinician mood ratings <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_8y6xnmb">Additionally, Grünerbl et al <ref type="bibr" target="#b8">[9]</ref> are investigating extending this research to enable the app to identify mood state changes based solely on objective sensor data.</s><s xml:id="_ykMaJYS">However, to our knowledge, there are currently no apps available for people with BD that have been subject to research evaluation to determine effectiveness.</s></p><p xml:id="_D9Yxzdf"><s xml:id="_WydwSvt">Previous reviews have found that apps currently available to consumers for other health conditions are unlikely to be supported by research data, nor be developed with reference to evidence-based practice.</s><s xml:id="_jyBe3wa">For example, an investigation of the content of smoking cessation apps found that apps had low concordance with guidelines, with an average guideline adherence score of 7.8 out of a possible total of 60 <ref type="bibr" target="#b9">[10]</ref>.</s><s xml:id="_HvnVjpu">Examining other chronic conditions with a strong self-management focus, a review of apps for asthma self-management determined that only 5% of those providing information were comprehensive, while 44% made recommendations that were not in line with treatment guidelines <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_BmVX4YZ">Similarly, a review of apps for human immunodeficiency virus / sexually transmitted disease prevention and care found that only 11% of assessed apps covered all literature-driven prevention areas <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_hFVca3s">Moreover, Donker et al <ref type="bibr" target="#b12">[13]</ref> performed a systematic review of apps for mental health and noted the striking disparity between the number of apps available and the number of scientific articles assessing the evidence base of mental health apps.</s><s xml:id="_dWndgFM">Similarly, a simultaneous review of health-related apps and research literature for a number of conditions noted the contrast between the number of research publications regarding the use of mobile technology to manage the investigated illnesses and the profusion of available apps <ref type="bibr" target="#b13">[14]</ref>.</s></p><p xml:id="_bPH6fNB"><s xml:id="_qn2Y2dR">An examination of the Google Play and Apple iOS app stores indicates that there is an abundance of publically available apps for BD despite the limited published research.</s><s xml:id="_GtUrZ8M">Therefore, there is little information accessible to consumers about the quality of available apps beyond the user "star" rating system and user reviews.</s><s xml:id="_ykNmQff">However, the popularity of an app is not necessarily a reliable indicator of its quality, effectiveness, or evidence base.</s><s xml:id="_CdtNKtj">The opportunity for mHealth to assist in the self-management of BD is feasible only if apps are of appropriate quality, and therefore, the aim of the current study was to identify the types of self-management apps available in the Google Play and iOS app stores and to assess the comprehensiveness and quality of their content for BD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6NzTkXB">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GBgP6vc">Search Criteria and Selection</head><p xml:id="_9TZryQU"><s xml:id="_eUpUsx5">A systematic review framework was applied to the search, screening, and assessment of apps.</s></p><p xml:id="_9GAutXS"><s xml:id="_Cr6ZCeT">Search terms to identify apps developed specifically for BD were derived through a preliminary search of the Google Play store.</s><s xml:id="_cmEPCcb">Relevant synonyms and layperson alternatives to the identified terms were determined and also included in the search.</s><s xml:id="_yscNkTr">Layperson alternatives were included because our aim was to assess apps that were specifically designed for consumers with BD, a group that may not use the technical terms of the disorder.</s><s xml:id="_uJ7DbcN">In this way, the following search terms were identified: bipolar, bi-polar, "manic depression", "mood swings", "mania" AND "mood", cyclothymia, and cyclothymic.</s><s xml:id="_cDdUgDz">On July 16, 2014, these terms were used to identify publically accessible apps for BD in the Australian Google Play and iOS app stores.</s><s xml:id="_FbrcVwq">Android apps were identified by a search of the Google Play store via the Web interface, while iOS apps were identified via the iTunes/iOS search application programming interface.</s><s xml:id="_RXVBzkr">Details of apps identified from the app stores were extracted from the search results including app name, description, and price.</s><s xml:id="_2m9XA66">Duplicate apps that were retrieved by multiple search terms on the same device platform were removed.</s><s xml:id="_DH4SGjy">Conversely, apps with different versions (eg, free/paid) or which appeared across different platforms were retained for comparison.</s><s xml:id="_rfRt6rR">Two reviewers (JN and ML) independently screened the app store description of each app.</s><s xml:id="_c4Zx97t">Apps were included in the review if the following criteria were met: (1) developed for BD, (2) aimed at consumers and/or caregivers, (3) available for download through official Android/iOS app stores, and (4) available in English.</s><s xml:id="_P6qdBAP">Discrepancies were identified and discussed until consensus was achieved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PcdrcU2">App Assessment</head><p xml:id="_VRzM9We"><s xml:id="_6qtnRsw">Apps meeting the inclusion criteria were downloaded onto either a Samsung Galaxy S4 mini (Android version 4.2.2) or an iPhone 5s (iOS version 7.1) for complete assessment.</s><s xml:id="_qEFAhsG">Two reviewers (JN and ML) performed the assessment of apps using a standard data extraction form.</s></p><p xml:id="_QGVUrCY"><s xml:id="_fJcHten">Descriptive characteristics related to the following features were extracted: (1) app accessibility, including platform, price, need for network connectivity, number of downloads, and average user-scored star rating for the app's entire history, (2) primary function, such as app store classification, app function (see below), and target audience, (3) app source, including provider type and details, crisis information, disclaimer presence, and app update schedule, and (4) privacy and security, presence of an accessible privacy policy, and the ability to password-protect data.</s></p><p xml:id="_VkwVa6V"><s xml:id="_V7NaS9j">The function of each app was determined through use of the app and classified as providing either information or self-management tools.</s><s xml:id="_eDAnQRC">Additional assessment was performed based on the identified function.</s><s xml:id="_vBMQ4Sr">Apps containing information about BD were assessed according to the comprehensiveness of its psychoeducation information and the quality of the information, as reflected by its concordance with evidence-based guidelines.</s><s xml:id="_TKGwecY">The comprehensiveness of BD psychoeducational information was assessed according to 11 fundamental topics of face-to-face psychoeducation interventions <ref type="bibr" target="#b14">[15]</ref>.</s><s xml:id="_tNA6ZCz">Core statements were derived from the main topics and goals of psychoeducation with reference to Colom and Vieta's Psychoeducational Manual for Bipolar Disorder <ref type="bibr" target="#b14">[15]</ref> (Table <ref type="table">1</ref>).</s><s xml:id="_wrkcSyJ">A clinical psychologist with experience with BD then reviewed the statements for accuracy and completeness.</s></p><p xml:id="_PQenM3h"><s xml:id="_kRy5wrK">Table 1.</s><s xml:id="_ymYSd9c">Core components of psychoeducation for BD. a</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Bepaftd">Criteria Topic</head><p xml:id="_ZgvYS9J"><s xml:id="_FgCJqqf">States that BD is biological in nature but interacts with environmental factors (diathesis-stress model).</s></p><p xml:id="_6uT8T2b"><s xml:id="_BJJwS9N">1. Facts about the nature of BD.</s></p><p xml:id="_5eqs5rE"><s xml:id="_7nMWCAB">States that BD is chronic and recurrent in nature and has a cyclic course.</s></p><p xml:id="_sCH7K7C"><s xml:id="_fUKGfr7">States common symptoms of both (hypo)mania and depression.</s><s xml:id="_KzTUSza">2. Information on common symptoms of each phase of the disorder.</s></p><p xml:id="_Kj3MdR8"><s xml:id="_p4PFCja">States that risk of suicide is associated with BD.</s></p><p xml:id="_6s54PfT"><s xml:id="_2YKqGSa">Outlines available pharmacotherapy for each illness phase: depression, mania, and prophylaxis.</s><s xml:id="_AujkqNQ">3. Treatment options for each illness phase.</s></p><p xml:id="_KkmrNv4"><s xml:id="_hcBZHZ7">Mentions psychotherapy as a treatment option for BD.</s></p><p xml:id="_FsVmzd6"><s xml:id="_JSJjHwA">States the importance of treatment adherence and states that risk of episode relapse is associated with abandonment of treatment.</s></p><p xml:id="_bhzWSv5"><s xml:id="_FxNf3nx">4. Treatment adherence, withdrawal, and side effects.</s></p><p xml:id="_wmT6vSs"><s xml:id="_HqmaTgj">States that psychoactive substances may trigger episodes.</s><s xml:id="_bwwYhhU">5. Substance use in BD.</s></p><p xml:id="_XBHzJV2"><s xml:id="_rdYa9vw">States common EWS of (hypo)mania and depression.</s><s xml:id="_mUYhp5M">6. Identification of episode warning signs (EWS).</s></p><p xml:id="_Vs5pmKw"><s xml:id="_EyNVpPH">States that EWS vary between people and indicates the importance of identifying personal episode warning signs.</s><s xml:id="_G4URRGc">Describes a support person as someone who is close to the patient, aware of their BD, and knowledgeable about the disorder.</s><s xml:id="_dAd2j3Y">7. Support networks and the role of support people or caregivers.</s></p><p xml:id="_2KPRKKR"><s xml:id="_c5aWZFh">States that a support network can assist in early detection of episodes.</s></p><p xml:id="_cN3xSXD"><s xml:id="_Rf5VAHJ">States the importance of having an action plan that provides a guide to stay well when episode EWS are detected.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8." xml:id="_PyrepXe">The role of an action plan.</head><p xml:id="_QFFWVuH"><s xml:id="_GbpzGfM">States common strategies that help prevent episodes once EWS are detected.</s></p><p xml:id="_wsYSzcp"><s xml:id="_nUn2RSt">States that regular habits, including sleep, are of importance in BD. 9.</s><s xml:id="_DF4RePD">The importance of routine.</s></p><p xml:id="_KTManay"><s xml:id="_pjQhAN5">States that regular schedules and better structuring of activities are key in BD management.</s></p><p xml:id="_a2yu3j5"><s xml:id="_k5Ru3Ab">States that stress plays an important role in episode relapse.</s><s xml:id="_5vNPnWh">10.</s><s xml:id="_XuqAqHd">Information on stress management and problem solving.</s></p><p xml:id="_F6KqvgX"><s xml:id="_ZpM4Yb6">States there are tools that help manage stress and anxiety.</s></p><p xml:id="_wtPU4QX"><s xml:id="_YZzYyTH">States common external factors that contribute to episode relapse.</s><s xml:id="_fcqTfyh">11.</s><s xml:id="_rtwQzqg">Episode risk-factors/triggers.</s><s xml:id="_pwUq4cj">a Topics based on Colom and Vieta's psychoeducation for BD manual <ref type="bibr" target="#b14">[15]</ref>.</s></p><p xml:id="_Un2Af8X"><s xml:id="_RWsT3dZ">The quality of BD information was assessed as the degree of concordance with the most recent treatment guidelines <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref> and prominent meta-analyses and reviews of evidence-based treatment for the acute phases of the disorder <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b20">21]</ref>.</s><s xml:id="_fHgmgpz">Thirteen statements were derived from treatment guidelines and meta-analyses for use as quality indicators in the app review (Table <ref type="table">2</ref>; <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>).</s><s xml:id="_XaaKsmQ">A psychiatrist previously involved in the development of the Australian and New Zealand Clinical Practice Guidelines for the Treatment of Bipolar Disorder <ref type="bibr" target="#b21">[22]</ref> then assessed and adjusted the statements for accuracy and comprehensiveness.</s><s xml:id="_xrbtEE5">Comprehensiveness and quality of information were calculated as a score out of 11 and 13 respectively, indicating how many of the core psychoeducation and guideline-derived statements were covered by the app's information.</s></p><p xml:id="_HSQQ2Nv"><s xml:id="_ZmwNHwW">Apps providing common tools for the management of BD were assessed against best-practice resources for their purpose.</s><s xml:id="_ZYnZyvf">Screening and assessment apps were assessed according to whether the app used a validated BD screening questionnaire or how closely it reflected current diagnostic criteria <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>.</s><s xml:id="_rerp5jj">Symptom monitoring apps were evaluated according to their similarity to well-known paper-and-pencil monitoring tools <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b27">28]</ref>.</s><s xml:id="_YXeffV8">Treatment apps for BD were assessed against statements derived from the core goals of three commonly used therapies for the disorder: CBT <ref type="bibr" target="#b28">[29]</ref>, IPSRT <ref type="bibr" target="#b29">[30]</ref>, and Family-Focused Therapy (FFT) <ref type="bibr" target="#b30">[31]</ref>.</s><s xml:id="_gESwWkj">As with statements used to assess the comprehensiveness and quality of information, treatment statements were reviewed by a clinical psychologist with experience with BD.</s><s xml:id="_FRPBv9X">Community support apps, which provided access to BD-orientated discussion boards, were assessed based on their methods of communication, and the level of moderation or oversight.</s></p><p xml:id="_a8fmwGT"><s xml:id="_bVUbvQP">Table 2. App quality assessment statements derived from BD treatment guidelines and meta-analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xSpvJ42">Associated guideline Statement</head><p xml:id="_aTsRnzJ"><s xml:id="_TjBxnDt">"Efficacy of lithium and divalproex is well established…substantial RCT data support atypical antipsychotic monotherapy with olanzapine, risperidone ER, quetiapine, ziprasidone, and aripiprazole for the first-line treatment of acute mania" Yatham et al, 2013, pp 4, 6 <ref type="bibr" target="#b18">[19]</ref> 1. Initiation of an atypical antipsychotic and/or mood stabilizer for the treatment of acute mania.</s><s xml:id="_HjyxbcU">"Overall, risperidone, olanzapine, and haloperidol seem to be the most effective evidence-based options for the treatment of manic episodes" Cipriani et al, 2011, pp 1314 <ref type="bibr" target="#b19">[20]</ref> "Lithium, lamotrigine, quetiapine…monotherapies, as well as lithium or divalproex plus selective serotonin reuptake inhibitor, olanzapine plus SSRI…recommended as first-line choices for bipolar depression" Yatham et al, 2013, pp 9 <ref type="bibr" target="#b18">[19]</ref> 2. Use of an atypical antipsychotic or mood stabilizer, with or without an antidepressant, for the treatment of bipolar depression.</s></p><p xml:id="_jAuTMHe"><s xml:id="_RvMtNdf">"Adjunctive antidepressants may be used for an acute bipolar I or II depressive episode when there is a history of previous positive response to antidepressants" Pacchiarotti et al, 2013, pp 1253 <ref type="bibr" target="#b20">[21]</ref> "The risk of mood switching is considered to be…somewhat greater with tri-and tetracyclics (and perhaps some SNRIs) than with most modern antidepressants" Pacchiarotti et al, 2013, pp 1256 <ref type="bibr" target="#b20">[21]</ref> 3. Antidepressant subtypes tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (SNRIs) are more likely to cause switching than serotonin-specific reuptake inhibitors (SSRIs).</s></p><p xml:id="_zUqXh5x"><s xml:id="_XTCPjUy">"monotherapy with some antidepressants, especially tricyclics, without an accompanying mood stabilizer, however, may be associated with an increased rate of treatment emergent affective switches (TEAS)" Grunze et al, 2010, pp 92 <ref type="bibr" target="#b16">[17]</ref> "Lithium, divalproex, olanzapine, and quetiapine, as well as lamotrigine (primarily for preventing depression)…continue to be first-line monotherapy options for maintenance treatment of BD" Yatham et al, 2013, pp 14 <ref type="bibr" target="#b18">[19]</ref> 4. Lithium, an atypical antipsychotic, or lamotrigine (where depression predominates) for maintenance treatment of BD.</s></p><p xml:id="_XHX9AUz"><s xml:id="_rgFAyRS">"Lithium, olanzapine or valproate should be considered for long-term treatment of bipolar disorder" NCCMH, 2006, pp 5 <ref type="bibr" target="#b22">[23]</ref> "No response after 2 weeks, switch to another first choice medication, in severe mania, consider combination" Grunze et al, 2009, pp 104 <ref type="bibr" target="#b15">[16]</ref> 5. Change monotherapy or use combination therapy for treatment resistance.</s></p><p xml:id="_ar3yQcf"><s xml:id="_MJ6Megz">"If the patient has frequent relapses, or symptoms continue to cause functional impairment, switching to an alternative monotherapy or adding a second prophylactic agent should be considered."</s><s xml:id="_eVmmSff">NCCMH, 2006, pp 5 <ref type="bibr" target="#b22">[23]</ref> "Especially in very severe and psychotic depression, or in depression with severe psychomotor retardation, ECT has a major role" Grunze et al, 2010, pp 100 <ref type="bibr" target="#b16">[17]</ref> 6.</s><s xml:id="_Pj9beh3">The use of electroconvulsive therapy (ECT) for treatment resistant acute symptoms (particularly depression, but also mania).</s><s xml:id="_5SbXvZt">"ECT is recommended for bipolar depression after an antidepressant trial has failed" RANZCP, 2004, pp 288 <ref type="bibr" target="#b21">[22]</ref> "ECT is still a valuable last resource in severe delirious mania which is otherwise treatment refractory" Grunze et al, 2009, pp 102 <ref type="bibr" target="#b15">[16]</ref> "Plasma concentrations need to be checked on a frequent and regular basis until equilibrium in the therapeutic range as been achieved and thereafter.</s><s xml:id="_t6yvreK">It is recommended to check every 3-6 months" Grunze et al, 2013, pp 186 <ref type="bibr" target="#b17">[18]</ref> 7. Careful monitoring of blood levels is required where those correlate with treatment response (eg, lithium, valproate).</s></p><p xml:id="_RmXeDHX"><s xml:id="_P7yDCU7">"lithium is up titrated in small steps guided by individual experience and plasma level monitoring" Grunze et al, 2013, pp 186 <ref type="bibr" target="#b17">[18]</ref> "Renal and thyroid function should also be checked regularly, every 6-12 months depending on risks" Grunze et al, 2013, pp 186 <ref type="bibr" target="#b17">[18]</ref> 8. Careful monitoring of potential physical complications or side effects of treatments is required (eg, kidney, thyroid, and calcium with lithium; glucose and lipids with antipsychotics).</s><s xml:id="_WqTmSTJ">"Complete medication and laboratory investigations should be performed at baseline, with ongoing monitoring for weight changes and adverse effects of medication" Yatham et al, 2013, pp 29 <ref type="bibr" target="#b18">[19]</ref> "Important that women with bipolar disorder receive education early in the course of illness about the effects of mood stabilizing and other medications on contraceptive effectiveness, as 9. Women informed about ensuring that their medications are safe to take during breastfeeding and pregnancy.</s><s xml:id="_KGUHuAT">well as the need to plan medication management during pregnancy and the postpartum period" Yatham et al, 2005, pp 33 <ref type="bibr" target="#b23">[24]</ref> "The presentation and diagnosis of BD in children and adolescents remains controversial…diagnostic criteria for BD may not be systematically applied in some clinical settings."</s><s xml:id="_UF8ACXU">Yatham et al, 2013, pp 19 <ref type="bibr" target="#b18">[19]</ref> 10.</s><s xml:id="_mxPSEDy">Seek medical professional advice and/or a second opinion in diagnosis of BD in children, due to the controversy in this area.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Cds3rHQ">XSL • FO</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QgmYz8R">RenderX</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yUwNUTC">Associated guideline Statement</head><p xml:id="_Wnb4yAt"><s xml:id="_wXd3SKK">"Rapid cycling…is associated with greater severity of illness on a number of clinical measures" Yatham et al, 2005, pp 30 <ref type="bibr" target="#b23">[24]</ref> 11.</s><s xml:id="_BRpWHm6">Outlines difficulties in the treatment of rapid cycling BD.</s></p><p xml:id="_fk3Qv2J"><s xml:id="_ruKfQhF">"The prophylactic use of lithium in rapid cycling patients has been discouraged for a long time based on the observation of insufficient acute and prophylactic efficacy in these patients" Grunze et al, 2013, pp 184 <ref type="bibr" target="#b17">[18]</ref> "When used as adjuncts to pharmacotherapy, psychosocial interventions…have demonstrated significant benefits, both in the treatment of acute depressive episodes and also as long-term maintenance treatment…providing psychological treatments-and, in particular, brief psychoeducation, which has been demonstrated to be as effective as CBT at much lower cost-is an essential aspect of managing patients with BD" Yatham et al, 2013, pp 4 <ref type="bibr" target="#b18">[19]</ref> 12. Optimal treatment for most patients with BD will include psychological treatment as well as medication.</s></p><p xml:id="_WSvYBwN"><s xml:id="_yKa3kfb">"The primary long-term treatments are pharmacological, but psychological and psychosocial interventions have an important part to play" NCCMH, 2006, pp 33 <ref type="bibr" target="#b22">[23]</ref> "The advent of these therapies, both drug and psychological, means that the majority of patients with this recurrent and disabling condition may be effectively treated" RANZCP, 2004, pp 299 <ref type="bibr" target="#b21">[22]</ref> 13.</s><s xml:id="_dVWXT3u">Indicates that most patients benefit considerably from treatment for their BD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_n5hkAkT">Data Analysis</head><p xml:id="_kfchCyc"><s xml:id="_2rCdU2d">Descriptive statistics were used to summarize the results of the app assessment.</s><s xml:id="_qBWrP5K">Pearson product-moment correlation was performed to examine relationships between comprehensiveness and quality of information, and the average user rating of an app.</s><s xml:id="_R3DzC8c">Mann-Whitney U tests were performed to examine differences in comprehensiveness and quality of information by app price.</s><s xml:id="_7nXnj5H">Statistical significance was set at P&lt;.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cgxhWpa">Results</head><p xml:id="_wuzXvWK"><s xml:id="_qTRP7zs">Google Play and iOS app store searches identified 571 potential apps, of which 133 were removed as duplicates (identified on the same platform through more than one search term).</s><s xml:id="_5fvevzQ">Of the remaining 438 apps, 82 met inclusion criteria (see Multimedia Appendix 1 for a list of included apps).</s><s xml:id="_9GZJXem">Details about the inclusion and exclusion of apps are provided in Figure <ref type="figure" target="#fig_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4T93kpU">Description</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_z7hJzcW">Accessibility</head><p xml:id="_yv3FNTW"><s xml:id="_xu6Sb2S">Of the 82 included apps, 59 were available on the Android platform, 23 were available on iOS devices, and ten had versions for both platforms.</s><s xml:id="_xAtTQfk">Examining costs, 49 apps were free, and the median cost of paid apps was AU$1.70, with a minimum price of AU$.99 and a maximum of AU$16.99 (mean AU$3.05).</s><s xml:id="_z6KFMFD">Over half (n=48) did not require an active Internet connection after installation, 20 would not function in the absence of an Internet connection, and 14 needed connectivity for some features.</s><s xml:id="_NfZx3TS">Only the Google Play store reported the number of downloads of each app to date, indicated by a range.</s><s xml:id="_dDFjQbN">The median number of downloads was between 1000 and 5000 (information available for 53 of the apps).</s><s xml:id="_QJdnuB6">Fourteen of these 53 apps had been installed less than 100 times.</s><s xml:id="_bcKYtzp">The app store descriptions of 28 apps indicated that an insufficient number of users had rated the app over its lifetime to provide an average user rating.</s><s xml:id="_QDQBQZg">The mean average user rating of the remaining 54 apps was 3.5 out of a possible 5.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JUYKA2x">Primary Function</head><p xml:id="_zv2mtHs"><s xml:id="_xQrnkBX">On the app stores, apps for BD were classified as health and fitness (n=48), medical (n=15), lifestyle (n=6), books (n=3), social (n=2), and entertainment (n=1), with genre information unavailable for seven apps.</s><s xml:id="_cADnJkR">Thirty-one apps provided written information about the disorder, and one used animation to raise awareness.</s><s xml:id="_GWwhhQZ">The remaining 50 apps provided tools for the management of BD and included ten screening and assessment tests, 35 symptom monitoring apps, four community support discussion boards, and one treatment app.</s><s xml:id="_XRydYdc">No apps performed multiple functions.</s></p><p xml:id="_QsFykH2"><s xml:id="_M4NX8Ps">For 78 apps, the function of the app was clearly stated in the app store description.</s><s xml:id="_WgrRMMK">Apps with unclear descriptions either introduced the disorder without explaining the role of the app, were unclear between two distinct functions, or provided information for an unrelated app.</s><s xml:id="_kTEvZd7">Forty-nine apps were developed for use by patients, with four apps specifically designed for caregivers, 14 for the general public, and 15 for both patients and caregivers.</s><s xml:id="_7h4H8HD">According to the app store descriptions, no apps were developed for a specific BD clinical subgroup.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CJ6BUyh">App Source</head><p xml:id="_ThAFSGw"><s xml:id="_FgRXp9v">As far as we can discern, none of the 82 apps assessed had been subject to research evaluation.</s><s xml:id="_rw6eqUB">No apps cited published material about the feasibility or effectiveness of the app, either within the app or the app store description.</s><s xml:id="_NZgs3ZV">Furthermore, there was a lack of Google Scholar results upon a search of app names.</s></p><p xml:id="_3mfg6Uq"><s xml:id="_WetvXa5">The majority of apps were developed by commercial providers (n=48) or private individuals (n=20), followed by institutions (n=3), other types of providers (n=6) including, clinical groups and not-for-profit organizations, and unspecified (n=5).</s><s xml:id="_DPxnXeN">The app provider's name was included in 46 apps, of which 30 also included contact details; eight apps included only provider contact details.</s><s xml:id="_t9NUCVY">A disclaimer outlining that the app was not a replacement for consultation with a medical professional was provided in 23 of the 82 apps, including seven screening and assessment apps, and eight information apps.</s><s xml:id="_apAhVYh">A statement providing information and contact details of crisis resources was provided in only nine apps for BD.</s><s xml:id="_muTbJx9">A quarter of apps (n=19) had been updated within the last 6 months, with half of the apps updated within the last 17 months.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3hWwMWD">Privacy and Confidentiality</head><p xml:id="_muS87ha"><s xml:id="_UnEp7vd">Privacy policies were available, either in the app or as a link from the app store description, for 18 of the 82 apps.</s><s xml:id="_NtnjxWW">Of the 50 apps able to record personal data (screening and assessment, symptom monitoring, community support, and treatment apps), 12 had a privacy policy.</s><s xml:id="_XTDqP62">An account or password was needed to access these data for 19 of these apps.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HPzjBrT">Information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ptq4yUJ">Overview</head><p xml:id="_GAsCPHs"><s xml:id="_DmZSZeW">Apps containing information were more readily available on the Android (n=29) compared to the iOS (n=3) platform.</s><s xml:id="_g42qUb2">Of the 32 apps that provided health information, seven presented general health news stories about a variety of conditions, including BD, and a further six provided no disorder-specific information to assess.</s><s xml:id="_yxD582M">The remaining 19 information apps were assessed for comprehensiveness and quality.</s><s xml:id="_AX68v4Q">Of these 19 apps, all contained in-app information content, and four linked directly to additional external information.</s><s xml:id="_9wnatBk">In all cases, external material was referenced; however, just four credited the source of their in-app information.</s><s xml:id="_auxQ8R9">Although only three of the apps were classified on the app stores as books, the assessment revealed 12 information apps were repurposed ebooks.</s><s xml:id="_rF2yNfb">Although unattributed, many shared the same ebook content, with nine apps having the same information content as another app, but with differences in user interface layout, connectivity reliance, or wording.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_j5s3Utd">Comprehensiveness of Bipolar Disorder Psychoeducational Information</head><p xml:id="_sMutcGV"><s xml:id="_UBXtD3R">The comprehensiveness of the psychoeducation information presented in the apps is reported below (Table <ref type="table" target="#tab_2">3</ref>).</s><s xml:id="_v9eUfQC">Overall, apps covered an average of four of the 11 psychoeducation statements (SD 3.0).</s><s xml:id="_symb3k4">Two statements, concerning the importance of treatment adherence and the development of action plans as a guide to stay well, were not addressed by any app.</s><s xml:id="_PH3uNY8">Five of the apps contained no BD specific psychoeducation information in line with best practice, while the most comprehensive apps covered seven statements (seven apps).</s><s xml:id="_8MNv4pz">These seven apps were reproductions of the same content, although uncited.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cgVf4f4">Quality of BD information: Concordance With Evidence-Based Practice</head><p xml:id="_6QEjYUd"><s xml:id="_A33WeWb">Of the 13 evidence-based statements extracted from treatment guidelines for BD, an average of two statements were covered by apps (SD 2.3; Table <ref type="table" target="#tab_3">4</ref>).</s><s xml:id="_Fa6TrdW">Only three apps provided information aligned with more than three guidelines, covering four, seven, and eight statements, and six apps addressed no statements.</s><s xml:id="_E3MFpND">The app that covered seven statements comprised 50 chapters, with no logical structure and repeated unreferenced information.</s><s xml:id="_AtR5V9C">In contrast, the app that addressed eight statements contained information structured into six concise sections and referenced NHS Choices <ref type="bibr" target="#b31">[32]</ref>.</s><s xml:id="_BeXa36m"><ref type="formula">16</ref>) 1. Initiation of an atypical antipsychotic and/or mood stabilizer for the treatment of acute mania.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2" xml:id="_ZNZHTa9">(11)</head><p xml:id="_V8M6ut9"><s xml:id="_AXBz2GE">2. The use of an atypical antipsychotic or mood stabilizer, with or without an antidepressant, for the treatment of bipolar depression.</s><s xml:id="_rwYtysP">0 (0) 3. Antidepressant subtypes tricyclic antidepressants and SNRIs are more likely to cause switching than SSRIs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4" xml:id="_xdynRfa">(21)</head><p xml:id="_cFwc2Ss"><s xml:id="_k5XNJfd">4. Lithium, an atypical antipsychotic, or lamotrigine (where depression predominates) for maintenance treatment of BD. 1 (5) 5. Change monotherapy or use combination therapy for treatment resistance.</s><s xml:id="_DXsksEJ">9 (47) 6.</s><s xml:id="_ymfmW3g">The use of ECT for treatment resistant acute symptoms (particularly depression, but also mania).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2" xml:id="_ZYH7mA9">(11)</head><p xml:id="_PyDejhT"><s xml:id="_ZfTS6Fy">7. Careful monitoring of blood levels is required where those correlate with treatment response (eg, lithium, valproate).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1" xml:id="_BYRUCmZ">(5)</head><p xml:id="_7ZgAVrZ"><s xml:id="_t37FW2y">8. Careful monitoring of potential physical complications or side effects of treatments is required (eg, kidney, thyroid, and calcium with lithium; glucose and lipids with antipsychotics). 1 (5) 9. Women informed about ensuring that their medications are safe to take during breastfeeding and pregnancy.</s><s xml:id="_sDfXAx6">Across the apps that provided information about BD, four contained incorrect information, three of which incorrectly differentiated the different types of BD.</s><s xml:id="_X9MMg5g">Two contained critically wrong information; the first suggested, "take a shot of hard liquor a [sic] hour before bed" (app ID 404) to assist with sleep during a manic episode.</s><s xml:id="_dhxMTgK">The second incorrectly informed users about the types of BD and indicated that BD was contagious "sometimes [BD] can transfer to another relative if they spend too much time with you and listen to your depressive life" (app ID 28).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XV3Yk9X">User Ratings</head><p xml:id="_PMy5Knk"><s xml:id="_HK879wU">Neither comprehensiveness of psychoeducation information (r=-.11,</s><s xml:id="_9r8CtKH">P=.80) nor information quality (r=-.02,</s><s xml:id="_53RR34N">P=.96) were significantly correlated with average user ratings.</s><s xml:id="_S79FUNh">A Mann-Whitney U test also revealed no significant difference in comprehensiveness (U=30.5,</s><s xml:id="_JfNQWtG">Z=-1.2,</s><s xml:id="_cjfYSga">P=.22) or quality (U=42.5,</s><s xml:id="_5N56Hky">Z=-.21, P=.83) between free and paid apps.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xS5K9Ps">Tools</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6qw8rt3">Screening and Assessment</head><p xml:id="_SeuGxfE"><s xml:id="_Vrb5x68">Ten apps offered self-assessments to screen for BD, of which three were for children.</s><s xml:id="_bQNDKzM">Only three cited the source of the test, two of which used a validated screening measure (the M3 checklist) <ref type="bibr" target="#b32">[33]</ref>.</s><s xml:id="_mwWB77G">Two additional apps used the Mood Disorder Questionnaire <ref type="bibr" target="#b33">[34]</ref> without attribution.</s><s xml:id="_u4R6NFF">In total, only four of the 10 screening apps used validated measures, and six of the tests screened for only manic symptoms.</s></p><p xml:id="_hHfcrWZ"><s xml:id="_X7q2qGX">Of the apps that asked about symptoms of depression, three had a duty-of-care message at the end of the test, referring the user to clinical support if questions about suicidal ideation were answered positively.</s><s xml:id="_pWYANsk">Upon informing the user they had screened positively for BD, eight apps recommended visiting a health care professional, and two had the option for users to share the result on social media.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MjNVYvX">Symptom Monitoring</head><p xml:id="_A5S4cQE"><s xml:id="_pE7YsMa">In total, 35 apps were symptom monitoring tools, which aim to assist users with tracking the symptoms of their BD.</s><s xml:id="_ygu2M38">The number of apps monitoring mood, medication, sleep, and other symptoms is shown in Table <ref type="table" target="#tab_4">5</ref>.</s><s xml:id="_N2p4nk2">A mood scale designed for BD was defined as a continuous scale with "depressed" and "manic" at the extremes.</s><s xml:id="_8h4nYPz">Other scales used to monitor mood included using different emoticons to represent emotions (n=10), rating mood on a generic scale (n=8), or had users select from or rate a list of moods (n=4).</s><s xml:id="_WDwctxH">Thirty apps monitored factors not commonly included on established mood charts, with energy levels and anxiety the most common additions.</s><s xml:id="_watTXZt">These tracking options were customizable in nine apps, allowing users to monitor factors specifically relevant to their mood states.</s><s xml:id="_rc6J4mY">General customization of other features such as esthetics, profiles, and data reports was possible in 21 apps.</s><s xml:id="_NjMThyE">Alerts reminding users to track their mood were available in 22 of the 35 monitoring apps.</s><s xml:id="_EwnDkHb">Of these, 13 allowed users to designate a reminder time, six asked users to designate how many times per day to be reminded, and three had options for both.</s><s xml:id="_yjvqMF5">Over a sampling period of 3 days, seven apps failed to notify the user as directed.</s></p><p xml:id="_Twj6J8x"><s xml:id="_FjTmNqM">None of the 35 monitoring apps had a duty-of-care alert, that is, a message suggesting users contact a health care provider.</s><s xml:id="_4UbSEMz">This was tested by logging 3 consecutive days of severely depressed mood and indicating suicidal ideation in free-text notes.</s><s xml:id="_JJgmXkr">Inputted monitoring data was presented graphically by 30 apps, could be exported from 20, and shared via social media by seven.</s><s xml:id="_YTXenAT">Back-up of personal monitoring data was available in only six apps.</s><s xml:id="_mMs3QMX">No app used the sensor capabilities of the smartphone to enhance monitoring data beyond what is possible with paper-and-pencil resources, or as an attempt to validate subjective mood reporting with objective data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RtbxrxX">Treatment</head><p xml:id="_zdQkZXw"><s xml:id="_CXKqhRg">There was only one treatment app, which delivered a CBT intervention, although it had not been specifically developed for BD.</s><s xml:id="_ssg7PGZ">An analysis of treatment content against common treatment features of CBT, IPSRT, and FFT confirmed that the app was based on CBT principles, with three of the six CBT items endorsed, and none related to other therapies.</s><s xml:id="_nHJDCdE">However, the source or evidence base of the CBT presented in the app was not referenced.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GKJD67z">Community Support</head><p xml:id="_34eBpsx"><s xml:id="_FkN3hd3">Four community apps gave users access to BD-orientated discussion boards, where members sought information and support.</s><s xml:id="_EUNbAr6">App communities were for consumers and family/caregivers and allowed communication via forum posts and private messages.</s><s xml:id="_3MjWx4d">Site owners for each app monitored forum post communication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uKjjFuv">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_kmcSAK7">Principle Findings and Comparison With Prior Work</head><p xml:id="_W57GvwX"><s xml:id="_qKuh7pY">This assessment of apps for BD indicates that most currently available apps do not reference clinical practice guidelines, standard psychoeducation information, or established self-management tools.</s><s xml:id="_Ccymby7">Apps were available for a variety of uses including disorder information (38%), and management tools such as screening and assessment (12%), symptom monitoring (43%), and community support (5%).</s><s xml:id="_Ws5HMc2">Interestingly, no apps combined these functions to provide both information and self-management tools.</s><s xml:id="_B42Gr9b">Furthermore, while all the assessed apps mentioned BD in their app store description, the content evaluation indicated few had been designed specifically for the disorder.</s><s xml:id="_6vzCAdp">For example, only a third of mood monitoring apps provided a BD specific mood scale, with the remaining apps using scales inadequate for the population.</s><s xml:id="_94ScZ3r">Furthermore, merely half of the apps claiming to provide information about BD actually provided disorder-specific information to be assessed for comprehensiveness and quality.</s><s xml:id="_wKdubrb">Disappointingly, apps that did provide BD specific information had low levels of adherence to quality assessment criteria, neither comprehensively addressing main psychoeducation domains, nor endorsing evidence-based practice guidelines.</s><s xml:id="_tBNcW72">The app that correctly addressed the most treatment guideline criteria was Your MD's Symptom Checker (app ID 39), which referenced NHS Choices <ref type="bibr" target="#b31">[32]</ref>, and presented information concisely and coherently (only BD information was assessed).</s><s xml:id="_QDW5S87">Overall, comprehensiveness and quality scores were low and not correlated with average user ratings, confirming that an app's popularity is not an accurate gauge of its content.</s><s xml:id="_EM2ZcF5">However, with only a third of information apps citing their information source, users are denied other important information by which to make informed judgments about an app's robustness and credibility.</s></p><p xml:id="_PA7kDAX"><s xml:id="_NDANPTU">Apps that offered tools to assist with the management of BD were also inconsistent in quality.</s><s xml:id="_bUH8gdv">Few screening and assessment apps citied the source of the test; additionally, a Google search of each app's assessment questions revealed that less than half used validated screening measures.</s><s xml:id="_AaC8PUD">Only one treatment app was included in the review, and while it covered half of the CBT treatment domains, it was not specifically designed for the needs of people with BD.</s><s xml:id="_3RtErmh">Symptom monitoring was the most prevalent self-management tool offered by apps.</s><s xml:id="_D6J5WdP">However, only a third allowed users to track all three symptoms standard in traditional monitoring tools: mood, sleep, and medication.</s><s xml:id="_BdqnYmS">The high proportion of monitoring apps that did not feature a notification or alert function to remind users to input daily mood data was unexpected.</s><s xml:id="_EpS4vSH">As the ability to remind users to complete monitoring in situ is a major advantage of this technology, it is surprising that more than a third of monitoring apps did not utilize this function, and a further seven did not ensure the feature functioned as intended.</s><s xml:id="_gJAQ4AU">It was also an unexpected finding that no symptom monitoring apps used the smartphone's sensors to supplement the user-inputted monitoring data.</s><s xml:id="_wPtUnaW">Torous et al <ref type="bibr" target="#b34">[35]</ref> found that all published articles regarding apps for bipolar disorder focused on the use of passive sensor-enabled data collection with supplemental or no user input.</s><s xml:id="_esafbkM">This is another example of the disconnect between emerging research in this area, and apps currently available for the disorder.</s></p><p xml:id="_aGYGZgV"><s xml:id="_6RYCF4r">These results are consistent with findings of reviews assessing apps of other heath domains.</s><s xml:id="_U9g6fst">Unfortunately, many of these reviews examine quality using the information provided in the app store description rather than assessing app content against evidence-based clinical guidelines <ref type="bibr" target="#b35">[36]</ref>.</s><s xml:id="_geuhe4C">However, those that do assess content have found similarly low endorsement of quality criteria.</s><s xml:id="_Y5BGY4V">Huckvale et al <ref type="bibr" target="#b10">[11]</ref> assessed asthma information against evidence-based asthma treatment guidelines and reported that the most endorsed guideline was cited by only 32% of apps.</s><s xml:id="_aHZcXQU">A similarly low concordance with guidelines was found in a review of smoking cessation apps <ref type="bibr" target="#b9">[10]</ref>.</s><s xml:id="_jdTNJhP">While a recent review of depression apps did not assess content, it highlighted another difficulty faced by users of health apps.</s><s xml:id="_2jvA3JS">Shen et al <ref type="bibr" target="#b36">[37]</ref> reported that a search for depression on the five major app stores yielded three times more non-related apps than depression apps <ref type="bibr" target="#b36">[37]</ref>.</s><s xml:id="_aqb2qQ9">In the current study, 78% of apps were excluded due to not being related to BD or not having a BD specific aim.</s><s xml:id="_f7BDfU8">This suggests an app's quality is not the only challenge consumers face in identifying appropriate apps, as irrelevant alternatives dominate search results.</s><s xml:id="_WPTvEWF">Together, these findings suggest that the results of the current study reflect a wider problem of app availability and quality across health conditions.</s></p><p xml:id="_ZbAxnM6"><s xml:id="_PtHpCe9">Rarely considered, the lack of privacy policies made available to app users was another area in which apps developed for BD fell short of optimal standards.</s><s xml:id="_U59Da7E">A recent review by Dehling et al of information security and privacy of mobile health apps characterized apps that had access to mental health information as high sensitivity <ref type="bibr" target="#b37">[38]</ref>.</s><s xml:id="_cS3KyVa">The review identified health monitors, state of health tests, treatment reminders, and health records, which included disease management tools, as the highest privacy and security risks <ref type="bibr" target="#b37">[38]</ref>.</s><s xml:id="_AnJkqVV">However, only a quarter of the assessed BD self-management tools, which would fall into the above categories, provided a statement indicating how data would be protected, stored, and shared.</s><s xml:id="_T6xyjCs">Sunyaev et al <ref type="bibr" target="#b38">[39]</ref> reported a similar absence of mHealth privacy policy availability.</s><s xml:id="_QyqPnad">Their assessment of health apps found that only 30.5% provided privacy policies, two-thirds of which did not address the app specifically <ref type="bibr" target="#b38">[39]</ref>.</s><s xml:id="_45Y3AK8">This represents a problematic lack of transparent reporting of how apps handle personal and mental health-related data.</s><s xml:id="_TsjtTTF">As the use of apps in health care becomes more common, the topic of information privacy will continue to grow in relevance, as privacy and security consistently feature as major considerations of users <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b37">38]</ref>.</s><s xml:id="_wXVR5Vd">Therefore, the time to ensure structures are in place to address privacy and security is now.</s></p><p xml:id="_gSyTHYA"><s xml:id="_aCcMkwk">While apps asked users to input personal health data, very few responded to indications that users were unwell.</s><s xml:id="_eXtEJGm">In fact, only three apps responded to users indicating severe extremes of mood or suicidal ideation.</s><s xml:id="_95k6C4S">A lack of response to severity of recorded symptoms was also noted by Huckvale et al <ref type="bibr" target="#b10">[11]</ref> in asthma management tools.</s><s xml:id="_GRbmwvw">Although both psychoeducation and clinical guidelines emphasize the importance of the ability to identify and respond to indications of mood change, few apps assisted users by informing them of such changes.</s><s xml:id="_3Pd8pjS">This identification and response to indicators of change in mood forms the basis of action plans or stay well plans.</s><s xml:id="_yUEDTUA">Action plans are a common feature of psychoeducation <ref type="bibr" target="#b14">[15]</ref> and combine information about early warning signs and factors that may ameliorate them into a plan that aims to prevent episode relapse.</s><s xml:id="_XtUaH2c">Action plans are also a common self-management tool used by people with BD to stay well <ref type="bibr" target="#b39">[40,</ref><ref type="bibr" target="#b40">41]</ref>.</s><s xml:id="_GnGQ8pP">A cohort of individuals that had not experienced an episode of BD for more than 2 years were interviewed about their strategies for staying well <ref type="bibr" target="#b40">[41]</ref>.</s><s xml:id="_VUEryDr">All participants discussed the importance of a tailored and revised stay well plan, which identified triggers and early warning signs and designated strategies to intervene.</s><s xml:id="_aP8QbFw">However, no information apps mentioned action plans, and no self-management tools assisted users in the development of an action plan.</s><s xml:id="_DayvzFZ">Together with the lack of response to user input, this represents a missed opportunity for the facilitation of important self-management practices by mobile technology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DcE46gm">Limitations</head><p xml:id="_5AQMph8"><s xml:id="_7rQuZNw">The current study is not without its limitations.</s><s xml:id="_mEQmH5P">A possible limitation is that the apps assessed were those available through the Australian Google Play and iOS app stores, and app availability may differ globally.</s><s xml:id="_zUCbBtH">This may affect the generalizability of results to apps available in other locations.</s><s xml:id="_uRxKxFY">However, a search of the Australian, British, and American iTunes app stores using the primary search term "bipolar" indicated that results were remarkably comparable.</s><s xml:id="_kEpgzAd">In total, 97% of apps were available in all three regions, with only three apps exclusively available in the American store.</s><s xml:id="_9ukR2ZY">Therefore, at least in English-speaking countries, apps appear to be universally available, and this review provides a representative overview of the apps available internationally.</s><s xml:id="_zGcu3jm">A second possible limitation is that while this study is novel in that it provides, to our knowledge, the first assessment of apps for BD in respect to clinical guidelines, psychoeducation principles, and self-management tools, it does so for a snapshot of apps available when the search was performed in July 2014.</s><s xml:id="_6bZudzf">As such, with changing nature of the Google Play and iOS app stores, the marketplace of apps for BD will differ by time of publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_duR6fHM">Conclusions</head><p xml:id="_CSYPXYz"><s xml:id="_q58Dbxe">With the exponential increase in the use of smartphones, there has been an increased interest in the use of apps for information dissemination and disease management.</s><s xml:id="_4WgrSHt">However, this study's findings highlight important shortcomings in current app marketplace offerings for BD, suggesting that apps are developed independently of research data, and without reference to best practice clinical guidelines.</s><s xml:id="_DKQsS4y">These results indicate that clinicians looking to recommend apps to supplement treatment should exercise caution with app selection and that policy makers and the research community need to consider ways of assuring app quality.</s><s xml:id="_H3VEMDr">There is an opportunity for mental health research to develop quality evidence-based mobile interventions that assist with the management of BD.</s><s xml:id="_VeFxQWw">However, with the domains of research and technology currently moving at different paces, new frameworks for mobile mental health research are needed to prevent a lag in availability and to ensure that evidence-based apps are available to consumers.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_BwEYsV8"><s xml:id="_FtUNqhY">Figure 1.</s><s xml:id="_9VyRPzE">Flow diagram illustrating the exclusion of apps at various stages of the study.</s></p></div></figDesc><graphic coords="6,56.69,403.54,481.90,313.63" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>1 ( 5 ) 10 .</head><label>510</label><figDesc><div><p xml:id="_qus7yRc"><s xml:id="_ZzXsZks">Seek medical professional advice and/or a second opinion in diagnosis of BD in children, due to the controversy in this area.1 (5) 11.</s><s xml:id="_k2vRBbP">Outlines difficulties in the treatment of rapid cycling BD. 10 (53) 12. Optimal treatment for most patients with BD will include psychological treatment as well as medication.</s><s xml:id="_ZQzB34x">10 (53) 13.</s><s xml:id="_HWmNTxK">Most patients benefit considerably from treatment for their BD.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_KdBkeyE"><s xml:id="_6MfahzF">Comprehensiveness of psychoeducation topics covered by BD information apps.</s></p></div></figDesc><table><row><cell>Apps covering topic, n (%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc><div><p xml:id="_RyuXSgU"><s xml:id="_ntD9GN7">Quality of BD app information: concordance to BD treatment guidelines.</s></p></div></figDesc><table><row><cell>Apps covering topic,</cell></row><row><cell>n (%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 5 .</head><label>5</label><figDesc><div><p xml:id="_WdTAM4r"><s xml:id="_prYrCPu">Symptoms monitored by symptom monitoring apps for BD.</s></p></div></figDesc><table><row><cell>n (%)</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_nzAwf5f"><s xml:id="_PdWJjrh">J Med Internet Res 2015 | vol.</s><s xml:id="_s5SuB6n">17 | iss.</s><s xml:id="_6yVVtj9">8 | e198 | p. 2 http://www.jmir.org/2015/8/e198/</s><s xml:id="_rsx4qQ4">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_wPHwMXE"><s xml:id="_DzUDT6N">J Med Internet Res 2015 | vol.</s><s xml:id="_XXbNgFp">17 | iss.</s><s xml:id="_88sJXSF">8 | e198 | p. 3 http://www.jmir.org/2015/8/e198/</s><s xml:id="_nbX37Pt">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_S3X3FmF"><s xml:id="_hvME7xH">J Med Internet Res 2015 | vol.</s><s xml:id="_PAY2CtC">17 | iss.</s><s xml:id="_NKWGU82">8 | e198 | p. 4 http://www.jmir.org/2015/8/e198/</s><s xml:id="_j2rhdYZ">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_3"><p xml:id="_vgBJ98A"><s xml:id="_PUDCAyT">J Med Internet Res 2015 | vol.</s><s xml:id="_wNjf4RS">17 | iss.</s><s xml:id="_J3Mjwnd">8 | e198 | p. 5 http://www.jmir.org/2015/8/e198/</s><s xml:id="_wmPka33">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_4"><p xml:id="_SYJpz72"><s xml:id="_rpa4xjz">J Med Internet Res 2015 | vol.</s><s xml:id="_NGKCe76">17 | iss.</s><s xml:id="_6bvks4v">8 | e198 | p. 6 http://www.jmir.org/2015/8/e198/</s><s xml:id="_nnEcduf">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_5"><p xml:id="_EHSS2pK"><s xml:id="_AarfhgP">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_6"><p xml:id="_VzZwBdT"><s xml:id="_8UkWnAs">J Med Internet Res 2015 | vol.</s><s xml:id="_rdw48mP">17 | iss.</s><s xml:id="_PNEHvh5">8 | e198 | p. 8 http://www.jmir.org/2015/8/e198/</s><s xml:id="_bm79FSg">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_7"><p xml:id="_hTxv2Qd"><s xml:id="_NAPr2TT">J Med Internet Res 2015 | vol.</s><s xml:id="_8Mzwc9b">17 | iss.</s><s xml:id="_dG5KyzB">8 | e198 | p. 9 http://www.jmir.org/2015/8/e198/</s><s xml:id="_9RK3DGd">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_8"><p xml:id="_BRRBTE2"><s xml:id="_JkR68xR">J Med Internet Res 2015 | vol.</s><s xml:id="_cfxK72n">17 | iss.</s><s xml:id="_e5x83sP">8 | e198 | p. 10 http://www.jmir.org/2015/8/e198/</s><s xml:id="_Kx9PxbA">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_9"><p xml:id="_2Y4q9Jx"><s xml:id="_HuBVUFJ">J Med Internet Res 2015 | vol.</s><s xml:id="_SCw83ue">17 | iss.</s><s xml:id="_av8YewH">8 | e198 | p. 11 http://www.jmir.org/2015/8/e198/</s><s xml:id="_rf4FSkt">(page number not for citation purposes)</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_10"><p xml:id="_s9a6mVP"><s xml:id="_h3dSJwz">J Med Internet Res 2015 | vol.</s><s xml:id="_vSxDKgF">17 | iss.</s><s xml:id="_jNUTJGD">8 | e198 | p. 12 http://www.jmir.org/2015/8/e198/</s><s xml:id="_YBdSsZD">(page number not for citation purposes)</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_2JYEC9t">Acknowledgments</head><p xml:id="_3k2MKg8"><s xml:id="_WQtZMqV">The authors would like to thank <rs type="person">Professor Philip Mitchell</rs> and <rs type="person">Dr Vijaya Manicavasagar</rs> for their expert evaluation and feedback on the comprehensiveness and quality criteria statements.</s></p><p xml:id="_PUxsVJP"><s xml:id="_usn4CuK">This study is supported by a grant from the <rs type="funder">National Health and Medical Research Council (NHMRC)</rs> and forms part of research conducted by the <rs type="funder">NHMRC Centre for Research Excellence in Suicide Prevention</rs> (CRESP; <rs type="grantNumber">APP1042580</rs>).</s><s xml:id="_DezV5mA">Additionally, JN is supported by an <rs type="grantName">Australian Postgraduate Award</rs>, and HC by an <rs type="funder">NHMRC</rs> Fellowship <rs type="grantNumber">1056964</rs>.</s><s xml:id="_zjtsHR7">The <rs type="funder">NHMRC</rs> and APA were not involved in the study design, data collection, data analysis, report writing, and decision to submit the manuscript for publication.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_txCPGkg">
					<idno type="grant-number">APP1042580</idno>
					<orgName type="grant-name">Australian Postgraduate Award</orgName>
				</org>
				<org type="funding" xml:id="_3H2scPd">
					<idno type="grant-number">1056964</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uspbUtq">Conflicts of Interest</head><p xml:id="_vk4aRGq"><s xml:id="_eXhhVHh">None declared.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CPQbDct">Multimedia Appendix 1</head><p xml:id="_eeuMgpx"><s xml:id="_cAkKAte">List of apps included in the review.</s></p><p xml:id="_RDJnqGW"><s xml:id="_zvE9BcN">[PDF File (Adobe PDF File), 33KB-Multimedia <ref type="bibr">Appendix</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_epgukss">The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Miklowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Geddes</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-5618.2010.00807.x</idno>
		<idno>Medline: 20565440</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nwKTE6U">Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="327" to="334" />
			<date type="published" when="2010-05">2010 May</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Bopp JM, Miklowitz DJ, Goodwin GM, Stevens W, Rendell JM, Geddes JR. The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study. Bipolar Disord 2010 May;12(3):327-334 [FREE Full text] [doi: 10.1111/j.1399-5618.2010.00807.x] [Medline: 20565440]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<idno type="DOI">10.36724/2664-066x-2022-8-3-18-28</idno>
		<ptr target="http://www.ericsson.com/res/docs/2015/ericsson-mobility-report-feb-2015-interim.pdf" />
		<title level="m" xml:id="_gqvqxD7">Ericsson Mobility Report: On the pulse of the networked society</title>
		<imprint>
			<date type="published" when="2015-04-26">2015. 2015-04-26</date>
		</imprint>
	</monogr>
	<note>6Y4KpDV9G</note>
	<note type="raw_reference">Ericsson Mobility Report: On the pulse of the networked society. 2015. URL: http://www.ericsson.com/res/docs/2015/ ericsson-mobility-report-feb-2015-interim.pdf [accessed 2015-04-26] [WebCite Cache ID 6Y4KpDV9G]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_BGn2Ctn">Community attitudes to the appropriation of mobile phones for monitoring and managing depression, anxiety, and stress</title>
		<author>
			<persName><forename type="first">J</forename><surname>Proudfoot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hadzi</forename><surname>Pavlovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Manicavasagar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Whitton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.2196/jmir.1475</idno>
		<idno>Medline: 21169174</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7BcXPks">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">64</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Proudfoot J, Parker G, Hadzi Pavlovic D, Manicavasagar V, Adler E, Whitton A. Community attitudes to the appropriation of mobile phones for monitoring and managing depression, anxiety, and stress. J Med Internet Res 2010;12(5):e64 [FREE Full text] [doi: 10.2196/jmir.1475] [Medline: 21169174]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_QzfYYcj">Mobile interventions for severe mental illness: design and preliminary data from three approaches</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Depp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mausbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Granholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cardenas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ben-Zeev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Patterson</surname></persName>
		</author>
		<idno type="DOI">10.1097/nmd.0b013e3181f49ea3</idno>
		<idno>Medline: 20921861</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6MBSgrB">J Nerv Ment Dis</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="715" to="721" />
			<date type="published" when="2010-10">2010 Oct</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Depp CA, Mausbach B, Granholm E, Cardenas V, Ben-Zeev D, Patterson TL, et al. Mobile interventions for severe mental illness: design and preliminary data from three approaches. J Nerv Ment Dis 2010 Oct;198(10):715-721 [FREE Full text] [doi: 10.1097/NMD.0b013e3181f49ea3] [Medline: 20921861]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_ZJh7wnp">Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wenze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Armey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1177/0145445513518421</idno>
		<idno>Medline: 24402464</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PSqAnH7">Behav Modif</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="497" to="515" />
			<date type="published" when="2014-07">2014 Jul</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Wenze SJ, Armey MF, Miller IW. Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study. Behav Modif 2014 Jul;38(4):497-515 [FREE Full text] [doi: 10.1177/0145445513518421] [Medline: 24402464]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_KtzPXqP">An ecological momentary intervention to improve treatment adherence in bipolar disorder: Feasibility, acceptability, and preliminary data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wenze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">W</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Armey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Jc6AfRs">Bipolar Disorders</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">149</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl.</note>
	<note type="raw_reference">Wenze S, Miller IW, Armey M. An ecological momentary intervention to improve treatment adherence in bipolar disorder: Feasibility, acceptability, and preliminary data. Bipolar Disorders 2013;15(Suppl. 1):149.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_GHwxtC4">Developing a smart phone app to monitor mood, social rhythms, sleep and social activity: Technology to support effective management of bipolar disorder</title>
		<author>
			<persName><forename type="first">E</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Choudhury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Voida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abdullah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_f9vxrHr">The American College of Neuropsychopharmacology Annual Conference</title>
		<meeting><address><addrLine>Florida, United States</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2013-08-12">2013. Dec. 8-12, 2013</date>
		</imprint>
	</monogr>
	<note>Presented at</note>
	<note type="raw_reference">Frank E, Matthews M, Choudhury T, Voida S, Abdullah S. Developing a smart phone app to monitor mood, social rhythms, sleep and social activity: Technology to support effective management of bipolar disorder. 2013 Presented at: The American College of Neuropsychopharmacology Annual Conference; Dec. 8-12, 2013; Florida, United States.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_pECcm8Z">Smartphone data as objective measures of bipolar disorder symptoms</title>
		<author>
			<persName><forename type="first">M</forename><surname>Faurholt-Jepsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Bardram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Kessing</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.psychres.2014.03.009</idno>
		<idno>Medline: 24679993</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WA2ztwN">Psychiatry Res</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="124" to="127" />
			<date type="published" when="2014-06-30">2014 Jun 30</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Faurholt-Jepsen M, Frost M, Vinberg M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as objective measures of bipolar disorder symptoms. Psychiatry Res 2014 Jun 30;217(1-2):124-127. [doi: 10.1016/j.psychres.2014.03.009] [Medline: 24679993]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_jNStmNM">Smartphone-based recognition of states and state changes in bipolar disorder patients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Grünerbl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Muaremi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Osmani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bahle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tröster</surname></persName>
		</author>
		<idno type="DOI">10.1109/JBHI.2014.2343154</idno>
		<idno>Medline: 25073181</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tR4GMBY">IEEE J Biomed Health Inform</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="140" to="148" />
			<date type="published" when="2015-01">2015 Jan</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grünerbl A, Muaremi A, Osmani V, Bahle G, Ohler S, Tröster G, et al. Smartphone-based recognition of states and state changes in bipolar disorder patients. IEEE J Biomed Health Inform 2015 Jan;19(1):140-148. [doi: 10.1109/JBHI.2014.2343154] [Medline: 25073181]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_WdYjwET">iPhone apps for smoking cessation: a content analysis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Abroms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Padmanabhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thaweethai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Phillips</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2010.10.032</idno>
		<idno>Medline: 21335258</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_R6XyVhR">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="279" to="285" />
			<date type="published" when="2011-03">2011 Mar</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Abroms LC, Padmanabhan N, Thaweethai L, Phillips T. iPhone apps for smoking cessation: a content analysis. Am J Prev Med 2011 Mar;40(3):279-285 [FREE Full text] [doi: 10.1016/j.amepre.2010.10.032] [Medline: 21335258]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_hGuzZSh">Apps for asthma self-management: a systematic assessment of content and tools</title>
		<author>
			<persName><forename type="first">K</forename><surname>Huckvale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Car</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Morrison</forename><surname>Car</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
		<idno type="DOI">10.1186/1741-7015-10-144</idno>
		<idno>Medline: 23171675</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_txvj74H">BMC Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">144</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Huckvale K, Car M, Morrison Car J. Apps for asthma self-management: a systematic assessment of content and tools. BMC Med 2012;10:144 [FREE Full text] [doi: 10.1186/1741-7015-10-144] [Medline: 23171675]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_WCwm5jz">Mobile phone applications for the care and prevention of HIV and other sexually transmitted diseases: a review</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Muessig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Pike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Legrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Hightow-Weidman</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.2301</idno>
		<idno>Medline: 23291245</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bqnhNVt">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Muessig KE, Pike EC, Legrand S, Hightow-Weidman LB. Mobile phone applications for the care and prevention of HIV and other sexually transmitted diseases: a review. J Med Internet Res 2013;15(1):e1 [FREE Full text] [doi: 10.2196/jmir.2301] [Medline: 23291245]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_za44ewN">Smartphones for smarter delivery of mental health programs: a systematic review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Donker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Proudfoot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Birch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Christensen</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.2791</idno>
		<idno>Medline: 24240579</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JVsgNFg">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">247</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Donker T, Petrie K, Proudfoot J, Clarke J, Birch M, Christensen H. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res 2013;15(11):e247 [FREE Full text] [doi: 10.2196/jmir.2791] [Medline: 24240579]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_SQyPqrg">Mobile health applications for the most prevalent conditions by the World Health Organization: review and analysis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Martínez-Pérez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>De La Torre-Díez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">López-</forename><surname>Coronado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.2196/jmir.2600</idno>
		<idno>Medline: 23770578</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9RU438P">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">120</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Martínez-Pérez B, de la Torre-Díez I, López-Coronado M. Mobile health applications for the most prevalent conditions by the World Health Organization: review and analysis. J Med Internet Res 2013;15(6):e120 [FREE Full text] [doi: 10.2196/jmir.2600] [Medline: 23770578]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<author>
			<persName><forename type="first">F</forename><surname>Colom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vieta</surname></persName>
		</author>
		<idno type="DOI">10.1017/cbo9780511543685</idno>
		<title level="m" xml:id="_BNq4zWB">Psychoeducation manual for bipolar disorder</title>
		<meeting><address><addrLine>Melbourne</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Colom F, Vieta E. Psychoeducation manual for bipolar disorder. Melbourne: Cambridge University Press; 2006.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_msb5aqH">The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania</title>
		<author>
			<persName><forename type="first">H</forename><surname>Grunze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vieta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bowden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Licht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Möller</surname></persName>
		</author>
		<idno type="DOI">10.1080/15622970902823202</idno>
		<idno>Medline: 19347775</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3Ykjwxc">World J Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="85" to="116" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009;10(2):85-116. [doi: 10.1080/15622970902823202] [Medline: 19347775]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_hHtyY9j">WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression</title>
		<author>
			<persName><forename type="first">H</forename><surname>Grunze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vieta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bowden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Licht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Möller</surname></persName>
		</author>
		<idno type="DOI">10.3109/15622970903555881</idno>
		<idno>Medline: 20148751</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_N9RwU5C">World J Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="81" to="109" />
			<date type="published" when="2010-03">2010 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al; WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010 Mar;11(2):81-109. [doi: 10.3109/15622970903555881] [Medline: 20148751]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_TQwFTcA">WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder</title>
		<author>
			<persName><forename type="first">H</forename><surname>Grunze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vieta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bowden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Licht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Möller</surname></persName>
		</author>
		<idno type="DOI">10.3109/15622975.2013.770551</idno>
		<idno>Medline: 23480132</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v2QW2qj">World J Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="154" to="219" />
			<date type="published" when="2013-04">2013 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013 Apr;14(3):154-219. [doi: 10.3109/15622975.2013.770551] [Medline: 23480132]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_CgwkwCN">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Yatham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beaulieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alda</surname></persName>
		</author>
		<idno type="DOI">10.1111/bdi.12025</idno>
		<idno>Medline: 23237061</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6BQnBxa">Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="44" />
			<date type="published" when="2013-02">2013 Feb</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013 Feb;15(1):1-44. [doi: 10.1111/bdi.12025] [Medline: 23237061]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_rpJT55d">Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cipriani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barbui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Salanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stockton</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(11)60873-8</idno>
		<idno>Medline: 21851976</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QbT4UHn">Lancet</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="page" from="1306" to="1315" />
			<date type="published" when="2011-10-08">2011 Oct 8. 9799</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 2011 Oct 8;378(9799):1306-1315. [doi: 10.1016/S0140-6736(11)60873-8] [Medline: 21851976]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_zMp5DHy">The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders</title>
		<author>
			<persName><forename type="first">I</forename><surname>Pacchiarotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Baldessarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Nolen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Grunze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Licht</surname></persName>
		</author>
		<idno type="DOI">10.1176/appi.ajp.2013.13020185</idno>
		<idno>Medline: 24030475</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cfCPM2z">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1249" to="1262" />
			<date type="published" when="2013-11">2013 Nov</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013 Nov;170(11):1249-1262 [FREE Full text] [doi: 10.1176/appi.ajp.2013.13020185] [Medline: 24030475]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_FJef966">College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder</title>
		<author>
			<persName><forename type="first">Royal</forename><surname>Australiannew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zealand</forename></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1614.2004.01356.x</idno>
		<idno>Medline: 15144505</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xrR5AkU">Aust N Z J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="280" to="305" />
			<date type="published" when="2004-05">2004 May</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Royal AustralianNew Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2004 May;38(5):280-305. [doi: 10.1111/j.1440-1614.2004.01356.x] [Medline: 15144505]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<idno type="DOI">10.1192/pb.30.9.357-a</idno>
		<title level="m" xml:id="_gWxJKuH">Bipolar Disorder: the Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care</title>
		<meeting><address><addrLine>Leicester</addrLine></address></meeting>
		<imprint>
			<publisher>The British Psychological Society</publisher>
			<date type="published" when="2006">2006</date>
		</imprint>
		<respStmt>
			<orgName>National Collaborating Centre for Mental Health</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">National Collaborating Centre for Mental Health. Bipolar Disorder: the Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. Leicester: The British Psychological Society; 2006.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_kJ58Jnd">Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Yatham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>'donovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Macqueen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mcintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-5618.2005.00219.x</idno>
		<idno>Medline: 15952957</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t5mXJu4">Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">Suppl 3</biblScope>
			<biblScope unit="page" from="5" to="69" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yatham LN, Kennedy SH, O&apos;Donovan C, Parikh S, MacQueen G, McIntyre R, et al; Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005;7 Suppl 3:5-69. [doi: 10.1111/j.1399-5618.2005.00219.x] [Medline: 15952957]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_x2GpPJQ">Diagnostic and statistical manual of mental disorders</title>
		<idno type="DOI">10.1176/appi.books.9780890425596</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_PX35wpV">American Psychiatric Association</title>
		<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>American Psychiatric Pub</publisher>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>5th edition</note>
	<note type="raw_reference">American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. London: American Psychiatric Pub; 2013.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<idno type="DOI">10.1177/146642409311300216</idno>
		<title level="m" xml:id="_hrD3QpQ">The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main" xml:id="_Kz2MJz8">Daily mood graph for bipolar disorder</title>
		<idno type="DOI">10.1017/cbo9780511544187.031</idno>
		<ptr target="http://www.blackdoginstitute.org.au/docs/12.MoodChartforBipolarDisorder.pdf" />
		<imprint>
			<date type="published" when="2014">2014. 2015-04-26</date>
			<publisher>Black Dog Institute</publisher>
		</imprint>
	</monogr>
	<note>6Y4KfUjmM</note>
	<note type="raw_reference">Black Dog Institute. Daily mood graph for bipolar disorder. 2014. URL: http://www.blackdoginstitute.org.au/docs/12. MoodChartforBipolarDisorder.pdf [accessed 2015-04-26] [WebCite Cache ID 6Y4KfUjmM]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_8jX3yxe">National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Helzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Croughan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Ratcliff</surname></persName>
		</author>
		<idno type="DOI">10.1001/archpsyc.1981.01780290015001</idno>
		<idno>Medline: 6260053</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YN2SW9A">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="381" to="389" />
			<date type="published" when="1981-04">1981 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981 Apr;38(4):381-389. [Medline: 6260053]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m" type="main" xml:id="_STfYCuC">Cognitive therapy for bipolar disorder: A therapist&apos;s guide to concepts, methods and practice</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hayward</surname></persName>
		</author>
		<idno type="DOI">10.1002/9780470970256</idno>
		<imprint>
			<date type="published" when="2010">2010</date>
			<publisher>John Wiley &amp; Sons</publisher>
			<pubPlace>Singapore</pubPlace>
		</imprint>
	</monogr>
	<note>2nd edition</note>
	<note type="raw_reference">Lam D, Jones S, Hayward P. Cognitive therapy for bipolar disorder: A therapist&apos;s guide to concepts, methods and practice. 2nd edition. Singapore: John Wiley &amp; Sons; 2010.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<author>
			<persName><forename type="first">E</forename><surname>Frank</surname></persName>
		</author>
		<title level="m" xml:id="_ukrFDsw">Treating bipolar disorder: A clinician&apos;s guide to interpersonal and social rhythm therapy</title>
		<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>Guilford Press</publisher>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Frank E. Treating bipolar disorder: A clinician&apos;s guide to interpersonal and social rhythm therapy. London: Guilford Press; 2007.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<author>
			<persName><forename type="first">D</forename><surname>Miklowitz</surname></persName>
		</author>
		<title level="m" xml:id="_uqxpPnX">Bipolar disorder: A family-focused treatment approach</title>
		<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>Guilford Press</publisher>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miklowitz D. Bipolar disorder: A family-focused treatment approach. London: Guilford Press; 2010.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main" xml:id="_CXxzcbN">NHS Choices: Bipolar disorder</title>
		<idno type="DOI">10.1093/med/9780190908096.003.0005</idno>
		<ptr target="http://www.nhs.uk/Conditions/Bipolar-disorder/Pages/Introduction.aspx" />
		<imprint>
			<date type="published" when="2014">2014. 2015-04-26</date>
		</imprint>
		<respStmt>
			<orgName>Department of Health</orgName>
		</respStmt>
	</monogr>
	<note>6Y4LBDV0V</note>
	<note type="raw_reference">Department of Health. NHS Choices: Bipolar disorder. 2014. URL: http://www.nhs.uk/Conditions/Bipolar-disorder/Pages/ Introduction.aspx [accessed 2015-04-26] [WebCite Cache ID 6Y4LBDV0V]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_2bT8BDc">Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Gaynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Deveaugh-Geiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Macpherson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Schulberg</surname></persName>
		</author>
		<idno type="DOI">10.1370/afm.1092</idno>
		<idno>Medline: 20212303</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_32fHmUA">Ann Fam Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="160" to="169" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Gaynes BN, DeVeaugh-Geiss J, Weir S, Gu H, MacPherson C, Schulberg HC, et al. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care. Ann Fam Med 2010;8(2):160-169 [FREE Full text] [doi: 10.1370/afm.1092] [Medline: 20212303]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_zbMESda">Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Hirschfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Spitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Calabrese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Flynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Keck</surname></persName>
		</author>
		<idno type="DOI">10.1176/appi.ajp.157.11.1873</idno>
		<idno>Medline: 11058490</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gwmfG3M">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1873" to="1875" />
			<date type="published" when="2000-11">2000 Nov</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000 Nov;157(11):1873-1875. [Medline: 11058490]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_BmwUckY">Current research and trends in the use of smartphone applications for mood disorders</title>
		<author>
			<persName><forename type="first">J</forename><surname>Torous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Powell</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.invent.2015.03.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6pUsvu4">Internet Interventions</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="169" to="173" />
			<date type="published" when="2015-05">2015 May</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Torous J, Powell AC. Current research and trends in the use of smartphone applications for mood disorders. Internet Interventions 2015 May;2(2):169-173.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_9h9jjfs">A systematic review of quality assessment methods for smartphone health apps</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Bindhim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hawkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Trevena</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2014.0088</idno>
		<idno>Medline: 25469795</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hJAMNBB">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="97" to="104" />
			<date type="published" when="2015-02">2015 Feb</date>
		</imprint>
	</monogr>
	<note type="raw_reference">BinDhim NF, Hawkey A, Trevena L. A systematic review of quality assessment methods for smartphone health apps. Telemed J E Health 2015 Feb;21(2):97-104. [doi: 10.1089/tmj.2014.0088] [Medline: 25469795]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_h6puJvg">Finding a depression app: a review and content analysis of the depression app marketplace</title>
		<author>
			<persName><forename type="first">N</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Levitan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamilton-Page</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aar</forename><surname>Jadad</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.3713</idno>
		<idno>Medline: 25689790</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fmQH58b">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Shen N, Levitan M, Johnson A, Bender JL, Hamilton-Page M, Jadad AAR, et al. Finding a depression app: a review and content analysis of the depression app marketplace. JMIR Mhealth Uhealth 2015;3(1):e16 [FREE Full text] [doi: 10.2196/mhealth.3713] [Medline: 25689790]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_J6VFg2P">Exploring the Far Side of Mobile Health: Information Security and Privacy of Mobile Health Apps on iOS and Android</title>
		<author>
			<persName><forename type="first">T</forename><surname>Dehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sunyaev</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.3672</idno>
		<idno>Medline: 25599627</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YRRxGq3">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>FREE Full text</note>
	<note type="raw_reference">Dehling T, Gao F, Schneider S, Sunyaev A. Exploring the Far Side of Mobile Health: Information Security and Privacy of Mobile Health Apps on iOS and Android. JMIR Mhealth Uhealth 2015;3(1):e8 [FREE Full text] [doi: 10.2196/mhealth.3672] [Medline: 25599627]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_zCQ3ZzY">Availability and quality of mobile health app privacy policies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sunyaev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dehling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Mandl</surname></persName>
		</author>
		<idno type="DOI">10.1136/amiajnl-2013-002605</idno>
		<idno>Medline: 25147247</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aaNs9YA">J Am Med Inform Assoc</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="28" to="e33" />
			<date type="published" when="2015-04">2015 Apr</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sunyaev A, Dehling T, Taylor PL, Mandl KD. Availability and quality of mobile health app privacy policies. J Am Med Inform Assoc 2015 Apr;22(e1):e28-e33. [doi: 10.1136/amiajnl-2013-002605] [Medline: 25147247]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_zncYQvB">Self-management strategies used by &apos;high functioning&apos; individuals with bipolar disorder: from research to clinical practice</title>
		<author>
			<persName><forename type="first">G</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Amari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Michalak</surname></persName>
		</author>
		<idno type="DOI">10.1002/cpp.710</idno>
		<idno>Medline: 20572206</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8sb2sQa">Clin Psychol Psychother</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="95" to="109" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Murray G, Suto M, Hole R, Hale S, Amari E, Michalak EE. Self-management strategies used by &apos;high functioning&apos; individuals with bipolar disorder: from research to clinical practice. Clin Psychol Psychother 2011;18(2):95-109. [doi: 10.1002/cpp.710] [Medline: 20572206]</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_2FW49QW">Staying well with bipolar disorder</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Browne</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1614.2005.01542.x</idno>
		<idno>Medline: 15701069</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6sDqHjk">Aust N Z J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="187" to="193" />
			<date type="published" when="2005-03">2005 Mar</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Russell SJ, Browne JL. Staying well with bipolar disorder. Aust N Z J Psychiatry 2005 Mar;39(3):187-193. [doi: 10.1111/j.1440-1614.2005.01542.x] [Medline: 15701069]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
